Cited by 58Physical Activity and HealthDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Walking prescription of 10 000 steps per day in patients with type 2 diabetes mellitus: A randomised trial in Nigerian general practice

Open access
Fayehun, Ayorinde F, Olowookere, Olufemi O, Ogunbode, Adetola M, Adetunji, Adedotun A, Esan, Arinola·2018·British Journal of General Practice

Abstract

Background In clinical practice, translating the benefits of a sustained physically active lifestyle on glycaemic control in patients with type 2 diabetes mellitus (T2DM) is difficult. A walking prescription may be an effective alternative. Aim To examine the effect of a 10 000 steps per day prescription on glycaemic control of patients with T2DM. Design and setting Forty-six adults with T2DM attending a general outpatient clinic were randomised into two equal groups. The intervention group was given goals to accumulate 10 000 steps per day for 10 weeks, whereas the control group maintained their normal activity habits. Method Daily step count was measured with waist-mounted pedometer and baseline and endline average steps per day. Glycosylated haemoglobin (HbA1c), anthropometric, and cardiovascular measurements were also obtained. An intention-to-treat analysis was done. Results The average baseline step count was 4505 steps per day for all participants, and the average step count in the intervention group for the last 4 weeks of the study period was higher by 2913 steps per day (95% confidence interval [CI] = 1274 to 4551, F (2, 37.7) = 18.90, P<0.001). Only 6.1% of the intervention group participants achieved the 10 000 steps per day goal. The mean baseline HbA1c was 6.6% (range = 5.3 to 9.0). Endline HbA1c was lower in the intervention group than in the control group (mean difference −0.74%, 95% CI = −1.32 to −0.02, F = 12.92, P = 0.015) after adjusting for baseline HbA1c. There was no change in anthropometric and cardiovascular indices. Conclusion Adherence to 10 000 steps per day prescription is low but may still be associated with improved glycaemic control in T2DM. Motivational strategies for better adherence would improve glycaemic control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3399/bjgp18x694613

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. International Diabetes Federation. The global burden. In: IDF diabetes atlas. 5th edition. Brussels: IDF, 2011: 23-44.
  2. International Diabetes Federation. Regional overviews. In: IDF diabetes atlas. 5th edition. Brussels: IDF, 2011: 45-62

Cited by

Sorted by citations

Authors
Fayehun, A. F., Olowookere, O. O., Ogunbode, A. M., Adetunji, A. A., & Esan, A.
Affiliations
University College Hospital, Ibadan (NG)
Venue
British Journal of General Practice
Published
2018-01-15
Volume
68
Issue
667
Pages
e139-e145
ISSN
  • 0960-1643 (ISSN-L)
  • 1478-5242
OpenAlex
W2783368859
Cited by
58
References
25
Citations by year
2026: 6 · 2025: 3 · 2024: 10 · 2023: 4 · 2022: 20 · 2021: 7 · 2020: 5 · 2019: 2 · 2017: 1
FWCI
2.40
Type
journal article
Language
en
Open access
Locations
  • British Journal of General Practice (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Fogarty International Center (R24TW008878)
Topics
  • Health Sciences › Medicine › Physiology › Physical Activity and Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, 10,000 steps per day, physical activity, glycemic control, HbA1c, pedometers, step count, adherence, motivational strategies, general practice
MeSH terms
Adult, Diabetes Mellitus, Type 2, Exercise Therapy, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Nigeria, Patient Compliance, Walking, Treatment Outcome, Young Adult, General Practice, Accelerometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review